Clinical Nutrition Market Insights:
Clinical Nutrition market is projected to be worth USD 62.29 Billion by 2030, registering a CAGR of 7.1% during the forecast period (2022-2030), the market was valued at USD 33.60 Billion in 2021.
Clinical Nutrition Market Dynamics:
Clinical nutrition refers to the investigation and complete examination of the link between ingested food and total human body well-being. Nutritionists are in charge of evaluating all of a participant’s nutrients, especially how these nutrients are digested, transferred, absorbed, retained, metabolized, and used before and after they are expelled as human waste.
Driver:
The factors driving the growth of the clinical nutrition market are the rising population globally and the increasing prevalence of chronic, infectious, and metabolic diseases such as influenza. Further, rising cases of malnutrition, adoption of home healthcare facilities, and government healthcare programs to generate awareness are expected to strengthen the growth of the clinical nutrition market.
Restraint:
The factors hampering the growth of the clinical nutrition market are low awareness regarding the availability of clinical nutrition products. Further, stringent rules and regulations imposed by the government on product marketing and composition are expected to restrain the growth of the clinical nutrition market.
Opportunity:
Growing untouched markets in emerging countries such as China, Mexico, and India and rising clinical nutrition awareness, and early examination of malnutrition are the factors creating lucrative growth opportunities for the clinical nutrition market.
COVID-19 Analysis of Clinical Nutrition Market:
Covid-19 has had a significant impact on industries in the areas of growth, economy, health, and mental well-being. In this difficult environment, every sector is striving to provide the greatest services in terms of quality and safety. Covid-19 has had a significant impact on the clinical nutrition industry’s development. The immune system of the body is attacked by a viral infection, which combats it. According to the report, eating has a significant impact on an individual’s immune system, and a lack of nutrition increases illness vulnerability. This increased demand for and understanding of key nutrients needed to survive a pandemic.
Clinical Nutrition Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 62.29 |
| CAGR (2022-2030) | 7.1% |
| By Patient Type | Pediatric, Adult, Geriatric |
| By Route of Administration | Oral, Enteral, Parenteral |
| By Application | Cancer, Malnutrition, Neurological Disease, Gastrointestinal Disorders, Metabolic Disorders, Others |
| By geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Abbott Laboratories, Retrophin, Inc., QIAGEN N.V., Illumina Inc., PerkinElmer, Inc., BGI, Partek, Inc., Centogene A.G., Strand Life Sciences Pvt Ltd., Eurofins Scientific, Laboratory Corporation of America, Quest Diagnostics Inc., Invitae Corporation, 3billion, Inc., Arup Laboratories, Ambry Genetics, Macrogen, Inc., Baylor Genetics, Color Genomics, Inc., Health Network Laboratories. |
Clinical Nutrition Market Segment Analysis:
By Patient
The clinical nutrition market is divided into three categories based on patient type such as pediatric, adult, and geriatric. Due to an increase in the number of juvenile underweight patients, the pediatric sector maintained the major market share in 2020. Furthermore, rising underweight childbirths and increased awareness about the importance of nutritious diets drive the clinical nutrition market in the forecast period. However, due to a boost in the number of elderly patients and increased knowledge about clinical nutrition, the adult sector is predicted to develop the quickest, with the greatest CAGR throughout the projected timeline. Hence, the patient segment in the clinical nutrition market is expected to drive the growth of the market.
By Route of Administration
The clinical nutrition market is divided into three categories based on the delivery route such as oral, enteral, and parenteral. The oral method of administration took over the market in 2020 as oral administration is the easiest method of administration and allows the medicine to be self-administered. The oral route of administration is the most frequent and least intrusive method of medication delivery. The method is also considered affordable as it does not incur additional costs for the patient. These factors support the expansion of the oral segment in the clinical nutrition market during the forecast period.
By Application
The clinical nutrition market is divided into five applications such as cancer, malnutrition, neurological illness, gastrointestinal diseases, and metabolic disorders. Due to the increasing demand for good nutrition management and the rising number of premature birth rates, the malnutrition sector accounted for the highest market share in 20201. Furthermore, rising concern about imbalanced nutrition intake and diets, rising demand for correct care for inpatients and elderly patients, and increased awareness about proper nutrition drive clinical nutrition market expansion during the projected timeline.
By Region
The regional segment is divided into Asia Pacific, Europe, North America, the Middle East and Africa, and Latin America. Due to an increase in the number of chronic conditions such as cancer, diabetes, and heart attacks, North America held the greatest market share in 2020 in the clinical nutrition market. Furthermore, rising government expenditures on healthcare increased public-private collaborations, and rising disposable income promoted the expansion of the clinical nutrition industry. Furthermore, the rising frequency of metabolic illnesses and an ever-increasing senior population drive business expansion during the projection period. In contrast, Asia-Pacific is likely to lead the market over the coming years due to increased healthcare expenditures and an increase in the percentage of malnourished people.
Clinical Nutrition Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Route of Administration launches have accelerated the growth of the clinical nutrition market. Key players in the market include-
- Abbott Laboratories
- Retrophin, Inc.
- QIAGEN N.V.
- Illumina Inc.
- PerkinElmer, Inc.
- BGI
- Partek, Inc.
- Centogene A.G.
- Strand Life Sciences Pvt Ltd.
- Eurofins Scientific
- Laboratory Corporation of America
- Quest Diagnostics Inc.
- Invitae Corporation
- 3billion, Inc.
- Arup Laboratories
- Ambry Genetics
- Macrogen, Inc.
- Baylor Genetics
- Color Genomics, Inc.
- Health Network Laboratories
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Route of Administration Picture of Clinical Nutrition
- Global Clinical Nutrition Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Clinical Nutrition Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Route of Administration Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Clinical Nutrition demand
- Post-Covid Impact on Clinical Nutrition Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Clinical Nutrition Market Segmentation, by Revenue (USD Billion), (2022-2030)
- By Patient
- Pediatric
- Adult
- Geriatric
- By Route of Administration
- Oral
- Enteral
- Parenteral
- By Application
- Cancer
- Malnutrition
- Neurological Disease
- Gastrointestinal Disorders
- Metabolic Disorders
- Others
- By Patient
- Global Clinical Nutrition Market Overview, By Region
- North America Clinical Nutrition Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Patient
- By Route of Administration
- By Application
- Canada
- Mexico
- US
- Europe Clinical Nutrition Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Clinical Nutrition Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Clinical Nutrition Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Clinical Nutrition Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Clinical Nutrition Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Clinical Nutrition Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Abbott Laboratories
- Business Overview
- Business Financials (USD billion)
- Route of Administration Category, Patient Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Abbott Laboratories
- Retrophin, Inc.
- QIAGEN N.V.
- Illumina Inc.
- PerkinElmer, Inc.
- BGI
- Partek, Inc.
- Centogene A.G.
- Strand Life Sciences Pvt Ltd.
- Eurofins Scientific
- Laboratory Corporation of America
- Quest Diagnostics Inc.
- Invitae Corporation
- 3billion, Inc.
- Arup Laboratories
- Ambry Genetics
- Macrogen, Inc.
- Baylor Genetics
- Color Genomics, Inc.
- Health Network Laboratories
- Abbott Laboratories
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.